A new drug appeared to slash seizures up to 90% in children with a rare and devastating form of epilepsy called Dravet syndrome by tackling the underlying genetic mutation that causes the condition.
The findings are in an early-stage trial not…
Continue Reading
News Source: www.livescience.com

Leave a Reply